Nicolas Ferry graduated from Paris University where he received a Ph D in 1985 and a M.D. in 1990. He moved to Pasteur Institute for a post-doctoral stay in 1990 where he entered the field of gene therapy. Nicolas served as a scientist at the french National Institute for health Science (INSERM) for more than 25 years. He focused his interest in liver research. He eventually created his own INSERM lab in Nantes in 2009 dedicated to biotherapy for acquired and inherited liver diseases. Nicolas was also involved in clinical consultancy for hemochromatosis, and he contributed to clinical trials of cell based therapy for liver diseases. Nicolas served as a gene therapy expert for the french regulatory authority from 2000 to 2010. In 2011 he joined the agency as head of the department of vaccines, blood derived products and advanced therapies. He was also appointed Committee for Advanced Therapies (CAT) of the EMA in London from 2011 to 2016 and to the Scientific Advisory Working Group (SAWP) at EMA from 2013 to 2014. Nicolas is now senior advisor at the cell therapy department of Saint Louis Hospital in Paris and works as a private consusltant in the field of ATMPs. Nicolas co-authored more than 100 scientific publications.